If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

Share Price is delayed by 15 minutes
Get Live Data
23.25    1.25 (5.68%)
Bid:
23.25
Ask:
23.50
Spread: 0.25 (1.075%)
Market Cap: £432.70m
ENQ Live PriceLast checked at - London Stock Exchange

Intraday Enquest Share Chart

Term loan facility agreement

25 Aug 2023 14:09

RNS Number : 5115K
EnQuest PLC
25 August 2023
 

 

 

 

EnQuest PLC, 25 August 2023

 

Agreement of term loan facility

 

EnQuest PLC ('EnQuest' or the 'Group') is pleased to announce it has agreed a term loan facility (the 'loan') of up to $150 million, maturing in July 2027, which will rank junior to the Group's existing $500 million reserve based lending facility (the 'RBL') as a secured second lien instrument within the capital structure. As at 31 July 2023, only $240 million of the RBL facility was drawn against an original commitment of $500 million.

 

The loan proceeds will be used for general corporate purposes and are expected to provide an additional source of liquidity in advance of the October settlement of the 7% GBP retail bond. EnQuest expects to satisfy all conditions and complete the loan within 30 days from signing. EnQuest was advised by Rothschild & Co and Ashurst.

 

Within the loan, Double A Limited, a company beneficially owned by the extended family of Amjad Bseisu, has agreed to lend $9 million on the same terms and conditions as all other lending parties. This is considered a smaller related party transaction under Listing Rule 11.1.10. EnQuest has obtained written confirmation from a sponsor that, given the aforementioned terms and conditions, Double A's participation in the loan is fair and reasonable as far as EnQuest's shareholders are concerned.

 

Commenting on this agreement, EnQuest's Chief Financial officer, Salman Malik, said:

 

"We continue to de-lever our balance sheet and optimise our capital structure in response to the impact of the Energy Profits Levy on available borrowing capacity under the RBL. We are pleased to have secured this source of financing to extend our debt maturities and build optionality within the balance sheet as we look to support accretive growth opportunities. We thank our lending syndicate for their enhanced support."

 

- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRPAMJTMTMTBFJ
Date   Source Headline
19th Mar 202511:08 amRNSForm 8.5 (EPT/RI)-EnQuest plc
19th Mar 202511:07 amGNWDimensional Fund Advisors Ltd. : Form 8.3 - ENQUEST PLC - Ordinary Shares
19th Mar 202510:56 amRNSForm 8.5 (EPT/RI) - Enquest PLC
19th Mar 202510:12 amRNS20250318_ENQUEST PLC_8.5 EPT RI_UK_MLI
18th Mar 20256:24 pmRNSForm 8.3 - EnQuest PLC
18th Mar 20251:28 pmRNSForm 8.3 ENQUEST PLC
18th Mar 20251:12 pmRNSForm 8.3 - EnQuest plc
18th Mar 202512:00 pmRNSForm 8.5 (EPT/RI) ENQUEST PLC
18th Mar 202511:29 amGNWDimensional Fund Advisors Ltd. : Form 8.3 - ENQUEST PLC - Ordinary Shares
18th Mar 202511:17 amRNSForm 8.5 (EPT/RI) - Enquest PLC
18th Mar 202511:00 amRNSForm 8.5 (EPT/RI)-EnQuest plc
18th Mar 202510:40 amRNSForm 8.5 (EPT/NON-RI) EnQuest PLC
18th Mar 202510:37 amRNS20250317_ENQUEST PLC_8.5 EPT RI_UK_MLI
17th Mar 20251:34 pmRNSForm 8.3 - EnQuest PLC
17th Mar 202512:00 pmRNSForm 8.5 (EPT/RI) ENQUEST PLC
17th Mar 202511:43 amRNSForm 8.3 - EnQuest plc
17th Mar 202511:17 amRNSForm 8.5 (EPT/NON-RI)-EnQuest plc
17th Mar 202511:07 amRNSForm 8.5 (EPT/RI)-EnQuest plc
17th Mar 202511:02 amRNSForm 8.5 (EPT/RI) - Enquest PLC
17th Mar 202510:46 amRNSForm 8.3 ENQUEST PLC
17th Mar 202510:39 amRNSForm 8.3 - EnQuest PLC
17th Mar 202510:32 amRNS20250314_ENQUEST PLC_8.5 EPT RI_UK_MLI
14th Mar 20253:05 pmRNSForm 8.3 - EnQuest Plc
14th Mar 20252:12 pmRNSForm 8.3 ENQUEST PLC
14th Mar 202512:00 pmRNSForm 8.5 (EPT/RI) ENQUEST PLC
14th Mar 202511:09 amRNSForm 8.5 (EPT/RI) - Enquest PLC
14th Mar 202511:06 amRNSForm 8.5 (EPT/RI)-EnQuest plc
14th Mar 202510:28 amRNS20250313_ENQUEST PLC_8.5 EPT RI_UK_MLI
13th Mar 20253:20 pmRNSForm 8.3 - EnQuest plc
13th Mar 20253:12 pmRNSForm 8.3 ENQUEST PLC
13th Mar 20251:40 pmRNSForm 8.3 - EnQuest PLC
13th Mar 202512:00 pmRNSForm 8.5 (EPT/RI) ENQUEST PLC
13th Mar 202511:26 amRNSForm 8.5 (EPT/NON-RI)-EnQuest plc
13th Mar 202511:05 amRNSForm 8.5 (EPT/RI)-EnQuest plc
13th Mar 202510:44 amRNSForm 8.5 (EPT/RI) - Enquest PLC
13th Mar 202510:29 amRNS20250312_ENQUEST PLC_8.5 EPT RI_UK_MLI
12th Mar 20252:30 pmRNSForm 8.3 ENQUEST PLC
12th Mar 20252:19 pmRNSForm 8.5 (EPT/NON-RI) - OPD - Enquest PLC
12th Mar 20252:18 pmRNSForm 8.5 (EPT/NON-RI) - OPD - Enquest PLC
12th Mar 20251:47 pmRNSForm 8.3 - EnQuest plc
12th Mar 202512:00 pmRNSForm 8.5 (EPT/RI) ENQUEST PLC
12th Mar 202511:45 amRNSForm 8.5 (EPT/RI) - Enquest PLC
12th Mar 202510:53 amRNSForm 8.5 (EPT/NON-RI)-EnQuest plc
12th Mar 202510:49 amRNSForm 8.5 (EPT/RI)-EnQuest plc
12th Mar 202510:47 amRNSForm 8.5 (EPT/NON-RI)-EnQuest plc
12th Mar 202510:40 amRNS20250311_ENQUEST PLC_8.5 EPT RI_UK_MLI
11th Mar 20253:30 pmRNSForm 8.3 - EnQuest plc
11th Mar 20251:51 pmRNSForm 8.3 - EnQuest plc
11th Mar 20251:30 pmRNSForm 8.3 ENQUEST PLC
11th Mar 202512:00 pmRNSForm 8.5 (EPT/RI) ENQUEST PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.